Kringle Pharma, Inc. (TYO:4884)

Kringle Pharma Balance Sheet

Financials in millions JPY. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	883.83	1,619	2,313	2,136	2,756	2,137
Cash & Short-Term Investments	883.83	1,619	2,313	2,136	2,756	2,137
Cash Growth	-57.94%	-30.00%	8.29%	-22.50%	28.97%	1.67%
Accounts Receivable	-	-	-	7	-	6
Other Receivables	72.15	60	57	74	67	76
Receivables	72.15	60	57	81	67	82
Inventory	250.1	250	294	364	349	315
Prepaid Expenses	-	20	23	14	11	12
Other Current Assets	759.82	106	68	22	24	88
Total Current Assets	1,966	2,055	2,755	2,617	3,207	2,634
Long-Term Investments	-	23	1	1	1	1
Other Long-Term Assets	24.62	1	1	-	-	-
Total Assets	1,991	2,079	2,757	2,618	3,208	2,635
Accounts Payable	28.51	1	1	-	1	-
Accrued Expenses	-	15	21	5	2	3
Current Income Taxes Payable	0.37	21	37	173	54	32
Other Current Liabilities	74.19	72	69	31	105	92
Total Current Liabilities	103.07	109	128	209	162	127
Other Long-Term Liabilities	666.49	662	522	388	258	2
Total Liabilities	769.56	771	650	597	420	129
Common Stock	117.28	64	11	97	59	51
Additional Paid-In Capital	2,946	2,888	2,835	3,095	3,057	2,755
Retained Earnings	-1,875	-1,672	-756	-1,185	-331	-301
Comprehensive Income & Other	32.14	28	17	14	3	1
Shareholders' Equity	1,221	1,308	2,107	2,021	2,788	2,506
Total Liabilities & Equity	1,991	2,079	2,757	2,618	3,208	2,635
Net Cash (Debt)	883.83	1,619	2,313	2,136	2,756	2,137
Net Cash Growth	-57.94%	-30.00%	8.29%	-22.50%	28.97%	1.67%
Net Cash Per Share	127.56	236.63	361.45	396.27	567.55	514.49
Filing Date Shares Outstanding	7.16	7.02	6.81	5.41	5.38	4.33
Total Common Shares Outstanding	7.16	7.02	6.81	5.41	5.38	4.33
Working Capital	1,863	1,946	2,627	2,408	3,045	2,507
Book Value Per Share	170.57	186.38	309.37	373.88	518.16	578.13
Tangible Book Value	1,221	1,308	2,107	2,021	2,788	2,506
Tangible Book Value Per Share	170.57	186.38	309.37	373.88	518.16	578.13

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.